Skip to content

A Study on the Promotion and Application of Combined Dural Puncture Epidural Analgesia and Programmed Intermittent Epidural Bolus in Primary Hospitals

A Study on the Promotion and Application of Combined Dural Puncture Epidural Analgesia and Programmed Intermittent Epidural Bolus in Primary Hospitals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092733
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor pain

Interventions

Continuous epidural analgesia (EP) combined with programmed intermittent epidural bolus (PIEB) for the labor analgesia group (EP group).:Continuous Epidural Analgesia (EP) Group: A puncture at the L2-
Combined spinal-epidural anesthesia (CSE) with programmed intermittent epidural bolus (PIEB) for the labor analgesia group (CSE group).:Combined Spinal-Epidural Anesthesia (CSE) Group: Puncture at the
Dural puncture epidural analgesia (DPE) combined with programmed intermittent epidural bolus (PIEB) for the labor analgesia group (DPE group).:Dural Puncture Epidural Analgesia (DPE) Gr

Sponsors

Lishui Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Gestational age of 37 weeks or greater, primiparous, singleton pregnancy. 2. Planned vaginal delivery. 3. Maternal request for labor analgesia. 4. Absence of contraindications to spinal anesthesia.

Exclusion criteria

Exclusion criteria: 1. Fetal cord entanglement, abnormal fetal movements, or amniotic fluid abnormalities. 2. History of allergy to labor analgesic medications in the mother. 3. Maternal bleeding tendencies or coagulopathy. 4. Maternal severe psychiatric disorders or cognitive impairments. 5. Presence of infectious diseases or other contraindications to labor analgesia. 6. Severe systemic diseases affecting the cardiovascular, respiratory, or neurological systems. 7. Maternal refusal to sign the informed consent form. 8. Any other special circumstances deemed inappropriate for study participation by the research team.

Design outcomes

Primary

MeasureTime frame
Time taken for NRS (Numeric Rating Scale) score = 3.;

Secondary

MeasureTime frame
Total dosage of anesthetic drugs.;Apgar scores at 1 minute and 5 minutes after birth, along with umbilical artery blood gas analysis.;

Countries

China

Contacts

Public ContactMin CHEN

Lishui Maternal and Child Health Hospital

83183875@qq.com+86 578 303 7202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026